| |
|
|
|
IBC Life Sciences, Arabella Sheraton Grand Hotel, Munich, Germany
24-27 January 2006
Following previous successes in the field, IBC present their first event to focus solely on Immunogenicity. Based on in-depth research with industry experts and potential delegates, this programme addresses the needs and uncertainties faced by the industry
|
|
|
|
|
|
|
|
Organized by:
|
|
IBC Life Sciences |
|
|
Invited Speakers:
|
|
* Dr Steven J Swanson, Director, Clinical Immunology,
Amgen Inc., USA
* Dr Joy A Williams, Regulatory/Research Scientist,
Division of Therapeutic Proteins, Laboratory of
Immunology, CDER, FDA, USA
* Dr Huub Schellekens, Director, Central Laboratory Animal
Institute, University of Utrecht, The Netherlands
* Dr Robin Thorpe, Head, Divison of Immunology and
Endocrinology, NIBSC, UK
* Dr Gary Kikuchi, Project Leader, Regulatory Affairs,
Immunomedics, USA
* Professor John D Isaacs, Professor of Clinical
Rheumatology and Director of Wilson Horne Immunotherapy
Centre, University of Newcastle, UK
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
23/01/2006
|
|
|
|
|
|
|
|
Registration:
|
|
For more information, please contact Anthony Andrews: anthony.andrews@informa.com
or visit the website:
http://www.ibc-lifesci.com/immune
|
|
|
E-mail:
|
|
anthony.andrews@informa.com
|
|
|
|
|
|
|
|
|